leisure time -WSS

leisure time

author：comprehensive 2025-08-20 09:39:53 - browse：5

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Who gets to use the title 'doctor'?

focus

WSS

Amylyx ALS drug fails large clinical trial

Global childhood vaccinations edge closer to pre

Congress likely to miss an opportunity to fix drug shortages issue

Care demand spikes challenge UnitedHealth’s provider arm

Does aspartame cause cancer? What new WHO guidance says

Change Healthcare cyberattack prompts Medicare loan program

hotspot

leisure time

hotspot

New air purifier tech could be key to improving indoor air quality

Mike Pence clashes with Tucker Carlson in Iowa

Medical records are filled with copy

Europe sees delivery challenges ahead on Alzheimer's therapies

Trump demands the U.S. pay no more for drugs than other countries … again

Michigan AG announces felony charges against 'fake electors' in 2020 election plot

In age of alternative facts, a scholarly course on calling out crap

Amylyx ALS drug fails large clinical trial

After affirmative action ruling, medical educators look to 'holistic review'

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

knowledge

Eli Lilly to acquire Versanis in heated race for weight loss drugs

NEJM study link tiny plastics in blood vessels to heart problems

UnitedHealth quietly bought dozens of outpatient centers

American woman kidnapped in Mexico freed after 8 months in captivity: FBI

Woman gored by Bison at Yellowstone

The Readout: Amylyx, Alumis, and Lundbeck drug updates

focus

knowledge

entertainment

focus